TransMedics (TMDX) stock jumps 7% premarket after earnings, 2026 revenue outlook
TransMedics Group Inc climbed roughly 7.3% before the bell on Wednesday. The organ-transplant tech firm posted its latest quarter and laid out a 2026 revenue goal, flagging another period of double-digit growth ahead. Shares were recently quoted at $147.88, up from Tuesday’s $137.78 close. https://www.investing.com/equities/transmedics-group-inc
